soul trial oral semaglutide cardiovascular outcomes nejm 2025 results Editorial Fellow Harleen Marwah, MD, summarizes the trial. Visit NEJM.org for the full results. #ACC25 #Cardiology #ClinicalTrials #MedTok #NEJM PDF) Oral Semaglutide and Cardiovascular

High-protein intake (2540g per meal) improves satiety, preserves muscle during weight loss, and pairs especially well with GLP-1 therapy

Sipping water throughout the day can help tremendously with both nausea and constipation

Our MIC injections contain a blend of vitamins B12, B1, B2, B3, and B6

5-Amino-1MQ is a small-molecule compound and selective inhibitor of NNMT (Nicotinamide N-methyltransferase), an enzyme involved in regulating NAD+ metabolism and one-carbon pathway signalling

In atherogenesis, pattern recognition receptors (PRRs) and scavenger receptors on intimal macrophages are known to recognize these OSEs as damage associated pathogens (DAMPs)

Primary In-Vitro Research Applications The unprecedented versatility, stability, and complementary nature of these three analogs make this specific formulation a cornerstone for academic and independent musculoskeletal studies